Revenue

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Biopharmaceutical Medicines Revenue	6.66T	6.07T	1.87T
Biopharmaceutical Medicines Revenue Growth	9.78%	224.01%	-3.31%
Chemical Medicines Revenue	517.00B	531.39B	500.78B
Chemical Medicines Revenue Growth	-2.71%	6.11%	-23.37%
Other Segments Revenue	7.24B	5.82B	5.14B
Other Segments Revenue Growth	24.30%	13.25%	32.66%
Adjustments to Revenue	-3,438.85B	-3,050.04B	-202.92B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Domestic Revenue	1.48T	1.55T	2.11T
Domestic Revenue Growth	-4.78%	-26.41%	1.08%
Asia Revenue	211.23B	192.46B	63.28B
Asia Revenue Growth	9.75%	204.16%	1.94%
Europe Revenue	1.65T	1.50T	-
Europe Revenue Growth	10.24%	-	-
North America Revenue	279.01B	168.09B	-
North America Revenue Growth	65.99%	-	-
Central and South America Revenue	123.60B	140.96B	-
Central and South America Revenue Growth	-12.31%	-	-

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Biopharmaceutical Medicines Operating Income	1.47T	1.20T	638.37B
Biopharmaceutical Medicines Operating Income Growth	22.90%	87.84%	3.36%
Chemical Medicines Operating Income	14.11B	9.18B	27.86B
Chemical Medicines Operating Income Growth	53.65%	-67.04%	-19.50%
Other Segments Operating Income	1.37B	505.60M	453.75M
Other Segments Operating Income Growth	170.76%	11.43%	54.17%
Adjustments to Operating Income	-693.18B	-716.79B	-15.20B

Updated Jun 30, 2025. Data Source: Fiscal.ai.